Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PRINCIPLE LABS LLC

NPI: 1346648870 · BETHLEHEM, PA 18020 · Clinical Medical Laboratory · NPI assigned 12/16/2014

$46.31M
Total Medicaid Paid
664,513
Total Claims
403,561
Beneficiaries
104
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPOLETE, JASON (COO)
NPI Enumeration Date12/16/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 59,634 $3.66M
2019 61,421 $4.02M
2020 81,721 $6.03M
2021 96,042 $7.92M
2022 125,154 $9.76M
2023 117,715 $7.41M
2024 122,826 $7.52M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 150,169 95,940 $18.47M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 145,744 86,053 $11.99M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 237,735 122,638 $10.70M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 15,242 10,811 $1.46M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 7,292 4,915 $815K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 8,511 6,506 $645K
87150 2,846 2,027 $558K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,244 2,271 $487K
87481 6,661 4,779 $167K
87653 6,533 4,670 $76K
87640 6,602 4,725 $75K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5,411 3,899 $74K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4,087 3,042 $70K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 4,081 3,035 $54K
87641 4,686 3,382 $46K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5,424 4,343 $46K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,236 2,020 $44K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3,149 2,733 $39K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,007 623 $36K
87500 3,573 2,606 $31K
82172 2,472 1,113 $30K
81226 104 92 $28K
87529 1,037 770 $27K
80061 Lipid panel 2,661 2,388 $24K
82670 1,162 1,032 $22K
82607 1,905 1,724 $20K
82747 1,567 1,407 $19K
84481 1,659 1,467 $19K
80050 General health panel 1,605 1,429 $18K
84146 1,363 1,232 $18K
81225 101 91 $18K
83036 Hemoglobin; glycosylated (A1C) 2,434 2,184 $15K
82728 1,469 1,298 $14K
87563 2,916 1,989 $12K
84153 877 793 $11K
80053 Comprehensive metabolic panel 1,757 1,544 $11K
87625 700 521 $11K
81227 82 78 $11K
84443 Thyroid stimulating hormone (TSH) 1,035 945 $11K
84439 1,730 1,528 $10K
83002 639 567 $8K
83970 196 183 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 982 704 $6K
86803 486 421 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 349 308 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 923 762 $4K
87631 350 247 $4K
85027 964 901 $4K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 401 292 $3K
82533 203 190 $3K
87340 434 360 $3K
86769 81 57 $3K
84403 147 129 $2K
87471 348 254 $2K
86706 273 240 $2K
86708 204 181 $2K
86709 354 316 $2K
87511 136 107 $1K
84144 91 79 $1K
83001 92 79 $1K
86480 121 102 $760.35
83550 110 96 $661.51
86705 145 129 $527.25
83540 99 95 $497.43
82977 100 92 $483.48
84480 247 208 $473.96
82150 89 77 $416.00
84100 126 120 $375.56
84436 360 318 $323.29
80074 28 20 $245.05
86703 55 40 $238.07
87561 101 65 $200.95
82043 44 44 $192.56
81003 337 314 $185.58
86780 51 47 $120.80
87493 77 52 $118.38
36415 Collection of venous blood by venipuncture 51 48 $91.56
80178 89 55 $79.17
86704 30 19 $74.52
80076 43 37 $74.08
86707 30 19 $71.51
87350 30 19 $71.26
84466 27 16 $70.16
82947 71 41 $33.97
80048 Basic metabolic panel (calcium, ionized) 48 34 $33.20
85045 27 16 $21.96
84155 34 30 $13.02
82040 33 29 $12.71
86592 12 12 $12.00
84478 36 32 $11.28
84460 17 13 $9.36
84450 17 13 $9.14
84075 18 13 $9.14
82247 17 17 $8.94
82565 40 40 $8.65
82465 35 31 $8.54
81002 76 74 $8.32
82436 16 16 $4.60
82310 16 16 $4.13
82374 16 16 $3.90
84295 16 16 $3.85
84132 16 16 $3.81
81001 15 13 $1.20
84479 25 21 $0.00